Latest Insider Transactions at Paratek Pharmaceuticals, Inc. (PRTK)
This section provides a real-time view of insider transactions for Paratek Pharmaceuticals, Inc. (PRTK). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Paratek Pharmaceuticals, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Paratek Pharmaceuticals, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Dec 13
2021
|
Michael Bigham Exec. Chairman of the Board |
SELL
Open market or private sale
|
Direct |
5,059
-0.55%
|
$20,236
$4.42 P/Share
|
Aug 17
2021
|
Adam Woodrow President & Chief Commercial |
SELL
Open market or private sale
|
Direct |
10,975
-2.14%
|
$54,875
$5.12 P/Share
|
Aug 17
2021
|
Randall B. Brenner Chief Development & Regulatory |
SELL
Open market or private sale
|
Direct |
8,766
-3.02%
|
$43,830
$5.12 P/Share
|
Aug 17
2021
|
Michael Bigham Exec. Chairman of the Board |
SELL
Open market or private sale
|
Direct |
32,030
-3.36%
|
$160,150
$5.12 P/Share
|
Aug 17
2021
|
William M. Haskel CLO, General Counsel & Sec. |
SELL
Open market or private sale
|
Direct |
9,692
-2.55%
|
$48,460
$5.12 P/Share
|
Aug 17
2021
|
Evan Loh CEO |
SELL
Open market or private sale
|
Direct |
33,931
-3.28%
|
$169,655
$5.12 P/Share
|
Aug 16
2021
|
Adam Woodrow President & Chief Commercial |
BUY
Grant, award, or other acquisition
|
Direct |
37,500
+6.82%
|
-
|
Aug 16
2021
|
Randall B. Brenner Chief Development & Regulatory |
BUY
Grant, award, or other acquisition
|
Direct |
21,250
+6.82%
|
-
|
Aug 16
2021
|
Michael Bigham Exec. Chairman of the Board |
BUY
Grant, award, or other acquisition
|
Direct |
75,000
+7.29%
|
-
|
Aug 16
2021
|
William M. Haskel CLO, General Counsel & Sec. |
BUY
Grant, award, or other acquisition
|
Direct |
23,125
+5.73%
|
-
|
Aug 16
2021
|
Evan Loh CEO |
BUY
Grant, award, or other acquisition
|
Direct |
75,000
+6.76%
|
-
|
Jun 30
2021
|
Minnie Baylor Henry Director |
BUY
Grant, award, or other acquisition
|
Direct |
19,200
+50.0%
|
-
|
Jun 04
2021
|
Evan Loh CEO |
SELL
Open market or private sale
|
Direct |
36,654
-3.68%
|
$329,886
$9.7 P/Share
|
Jun 04
2021
|
Michael Bigham Exec. Chairman of the Board |
SELL
Open market or private sale
|
Direct |
34,364
-3.76%
|
$309,276
$9.7 P/Share
|
Jun 04
2021
|
Randall B. Brenner Chief Development & Regulatory |
SELL
Open market or private sale
|
Direct |
9,978
-3.58%
|
$89,802
$9.7 P/Share
|
Jun 04
2021
|
William M. Haskel CLO, General Counsel & Sec. |
SELL
Open market or private sale
|
Direct |
7,561
-2.07%
|
$68,049
$9.7 P/Share
|
Jun 04
2021
|
Adam Woodrow President & Chief Commercial |
SELL
Open market or private sale
|
Direct |
17,182
-3.49%
|
$154,638
$9.7 P/Share
|
May 27
2021
|
Evan Loh CEO |
BUY
Grant, award, or other acquisition
|
Direct |
91,636
+8.43%
|
-
|
May 27
2021
|
Michael Bigham Exec. Chairman of the Board |
BUY
Grant, award, or other acquisition
|
Direct |
85,909
+8.59%
|
-
|
May 27
2021
|
Randall B. Brenner Chief Development & Regulatory |
BUY
Grant, award, or other acquisition
|
Direct |
28,636
+9.31%
|
-
|
May 27
2021
|
William M. Haskel CLO, General Counsel & Sec. |
BUY
Grant, award, or other acquisition
|
Direct |
28,636
+7.28%
|
-
|
May 27
2021
|
Adam Woodrow President & Chief Commercial |
BUY
Grant, award, or other acquisition
|
Direct |
42,955
+8.03%
|
-
|
Mar 30
2021
|
Adam Woodrow President & Chief Commercial |
BUY
Grant, award, or other acquisition
|
Direct |
177,750
+28.36%
|
-
|
Mar 30
2021
|
Michael Bigham Exec. Chairman of the Board |
BUY
Grant, award, or other acquisition
|
Direct |
281,250
+25.36%
|
-
|
Mar 30
2021
|
William M. Haskel CLO, General Counsel & Sec. |
BUY
Grant, award, or other acquisition
|
Direct |
132,750
+28.32%
|
-
|
Mar 30
2021
|
Randall B. Brenner Chief Development & Regulatory |
BUY
Grant, award, or other acquisition
|
Direct |
121,500
+32.68%
|
-
|
Mar 30
2021
|
Evan Loh CEO |
BUY
Grant, award, or other acquisition
|
Direct |
303,750
+25.14%
|
-
|
Feb 18
2021
|
Thomas John Dietz Director |
BUY
Grant, award, or other acquisition
|
Direct |
9,000
+23.08%
|
-
|
Feb 18
2021
|
Timothy R Franson Director |
BUY
Grant, award, or other acquisition
|
Direct |
9,000
+18.75%
|
-
|
Feb 18
2021
|
Rolf K Hoffmann Director |
BUY
Grant, award, or other acquisition
|
Direct |
9,000
+16.98%
|
-
|
Feb 18
2021
|
Kristine Peterson Director |
BUY
Grant, award, or other acquisition
|
Direct |
9,000
+18.75%
|
-
|
Feb 18
2021
|
Robert S Radie Director |
BUY
Grant, award, or other acquisition
|
Direct |
9,000
+21.82%
|
-
|
Feb 18
2021
|
Jeffrey Stein Director |
BUY
Grant, award, or other acquisition
|
Direct |
9,000
+20.17%
|
-
|
Dec 14
2020
|
Michael Bigham Exec. Chairman of the Board |
SELL
Open market or private sale
|
Direct |
26,063
-4.55%
|
$156,378
$6.71 P/Share
|
Dec 14
2020
|
Randall B. Brenner Chief Development & Regulatory |
SELL
Open market or private sale
|
Direct |
8,760
-6.37%
|
$52,560
$6.71 P/Share
|
Dec 14
2020
|
William M. Haskel CLO, General Counsel & Sec. |
SELL
Open market or private sale
|
Direct |
6,842
-3.26%
|
$41,052
$6.71 P/Share
|
Dec 14
2020
|
Adam Woodrow President & Chief Commercial |
SELL
Open market or private sale
|
Direct |
12,855
-4.52%
|
$77,130
$6.71 P/Share
|
Dec 14
2020
|
Evan Loh CEO |
SELL
Open market or private sale
|
Direct |
26,415
-4.21%
|
$158,490
$6.71 P/Share
|
Dec 11
2020
|
Michael Bigham Exec. Chairman of the Board |
SELL
Open market or private sale
|
Direct |
18,337
-3.1%
|
$110,022
$6.95 P/Share
|
Dec 11
2020
|
Randall B. Brenner Chief Development & Regulatory |
SELL
Open market or private sale
|
Direct |
6,164
-4.29%
|
$36,984
$6.95 P/Share
|
Dec 11
2020
|
William M. Haskel CLO, General Counsel & Sec. |
SELL
Open market or private sale
|
Direct |
4,814
-2.24%
|
$28,884
$6.95 P/Share
|
Dec 11
2020
|
Adam Woodrow President & Chief Commercial |
SELL
Open market or private sale
|
Direct |
9,045
-3.09%
|
$54,270
$6.95 P/Share
|
Dec 11
2020
|
Evan Loh CEO |
SELL
Open market or private sale
|
Direct |
18,585
-2.88%
|
$111,510
$6.95 P/Share
|
Nov 13
2020
|
Adam Woodrow President & Chief Commercial |
SELL
Open market or private sale
|
Direct |
15,000
-4.87%
|
$75,000
$5.93 P/Share
|
Nov 13
2020
|
William M. Haskel CLO, General Counsel & Sec. |
SELL
Open market or private sale
|
Direct |
6,892
-3.11%
|
$34,460
$5.93 P/Share
|
Nov 13
2020
|
Michael Bigham Exec. Chairman of the Board |
SELL
Open market or private sale
|
Direct |
26,250
-4.25%
|
$131,250
$5.93 P/Share
|
Nov 13
2020
|
Randall B. Brenner Chief Development & Regulatory |
SELL
Open market or private sale
|
Direct |
8,357
-5.5%
|
$41,785
$5.93 P/Share
|
Nov 13
2020
|
Evan Loh CEO |
SELL
Open market or private sale
|
Direct |
20,928
-3.14%
|
$104,640
$5.93 P/Share
|
Nov 12
2020
|
Adam Woodrow President & Chief Commercial |
BUY
Grant, award, or other acquisition
|
Direct |
37,500
+10.85%
|
-
|
Nov 12
2020
|
William M. Haskel CLO, General Counsel & Sec. |
BUY
Grant, award, or other acquisition
|
Direct |
23,125
+9.44%
|
-
|